CN Patent

CN103446071B — 一种口服片剂及其制备方法和用途

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2017-12-19 · 8y expired

What this patent protects

本发明涉及一种口服片剂及其制备方法和用途，该片剂中含有通式（I）所示的N‑[4‑[4‑(1,2‑苯并异噻唑‑3‑基)‑1‑哌嗪基]‑(2R,3R)‑2,3‑四亚甲基‑丁基]‑(1’R,2’S,3’R,4’S)‑2,3‑双环[2,2,1]庚烷二酰亚胺盐酸盐。本发明的口服片剂能够使药物在较短的时间内释放，保证了药物快速溶出，且药物成形性好。

USPTO Abstract

本发明涉及一种口服片剂及其制备方法和用途，该片剂中含有通式（I）所示的N‑[4‑[4‑(1,2‑苯并异噻唑‑3‑基)‑1‑哌嗪基]‑(2R,3R)‑2,3‑四亚甲基‑丁基]‑(1’R,2’S,3’R,4’S)‑2,3‑双环[2,2,1]庚烷二酰亚胺盐酸盐。本发明的口服片剂能够使药物在较短的时间内释放，保证了药物快速溶出，且药物成形性好。

Drugs covered by this patent

Patent Metadata

Patent number
CN103446071B
Jurisdiction
CN
Classification
—
Expires
2017-12-19
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.